Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine, AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-16-004066.pdf
0001558370-16-004066.rtf
0001558370-16-004066.xls
EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-17-001547.pdf
0001558370-17-001547.rtf
0001558370-17-001547.xls
EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-18-000862.pdf
0001558370-18-000862.rtf
0001558370-18-000862.xls
EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-19-001094.pdf
0001558370-19-001094.rtf
0001558370-19-001094.xls
EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-20-000784.pdf
0001558370-20-000784.rtf
0001558370-20-000784.xls
EX-101.SCH - EX-101.SCH
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-21-001141.pdf
0001558370-21-001141.rtf
0001558370-21-001141.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-22-001316.pdf
0001558370-22-001316.rtf
0001558370-22-001316.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-23-001465.pdf
0001558370-23-001465.rtf
0001558370-23-001465.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-24-001254.pdf
0001558370-24-001254.rtf
0001558370-24-001254.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K/A

Amendment to a previously filed 10-K

 View HTML
0001558370-18-006096.pdf
0001558370-18-006096.rtf
0001558370-18-006096.xls